EUVIMEDEUVIMED entdecken
Open Access

Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024

David Alfego, Alfonso C Hernandez-Romieu, Melissa Briggs-Hagen, Stephanie Dietz, Laura Gillim, Suzanne E Dale, Ajay Grover, Jeffrey Albrecht, Deborah Sesok-Pizzini, Marcia Eisenberg, Cria O Gregory, Brian Poirier

MMWR. Morbidity and Mortality Weekly Report · 28.11.2024 · 73 (47) · 1076-1081

DOI: 10.15585/mmwr.mm7347a2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 28.11.2024. Verfasst von David Alfego und 11 weiteren Autor:innen. Hauptthemen laut MEDLINE: Parvovirus B19, Human, Parvoviridae Infections, Blood Donors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In most persons, human parvovirus B19 (B19) causes a mild respiratory illness, but infection can result in adverse health outcomes in persons who are pregnant, immunocompromised, or who have chronic hemolytic blood disorders. During the first quarter of 2024, several European countries reported increases in B19 activity. In the United States, there is no routine surveillance for B19. To assess increases in B19 activity in the United States, trends in testing and results from two independent populations were examined: 1) the presence of immunoglobulin (Ig) M antibodies, a marker of recent infection, in clinical specimens ordered by physicians and 2) B19 nucleic acid amplification testing (NAAT) in pooled donor source plasma from a large commercial laboratory during 2018-2024. The proportion of IgM-positive clinical specimens reached 9.9% in the second quarter (Q2) of 2024 after remaining

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parvovirus B19, HumanParvoviridae InfectionsBlood DonorsHumansUnited StatesFemaleImmunoglobulin MAdultNucleic Acid Amplification TechniquesMaleMiddle AgedAntibodies, ViralChildAdolescentYoung AdultChild, Preschool

Substanzen

Immunoglobulin MAntibodies, Viral

Zitieren

APA

Alfego, D., Hernandez-Romieu, A. C., Briggs-Hagen, M., Dietz, S., Gillim, L., Dale, S. E., Grover, A., Albrecht, J., Sesok-Pizzini, D., Eisenberg, M., Gregory, C. O., & Poirier, B. (2024). Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024. MMWR. Morbidity and Mortality Weekly Report, 73(47), 1076-1081. https://doi.org/10.15585/mmwr.mm7347a2

Vancouver

Alfego D, Hernandez-Romieu AC, Briggs-Hagen M, Dietz S, Gillim L, Dale SE, et al. Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024. MMWR. Morbidity and Mortality Weekly Report. 2024;73(47):1076-1081. doi:10.15585/mmwr.mm7347a2

BibTeX
@article{Alfego2024,
  author = {Alfego, David and Hernandez-Romieu, Alfonso C and Briggs-Hagen, Melissa and Dietz, Stephanie and Gillim, Laura and Dale, Suzanne E and Grover, Ajay and Albrecht, Jeffrey and Sesok-Pizzini, Deborah and Eisenberg, Marcia and Gregory, Cria O and Poirier, Brian},
  title = {Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2024},
  volume = {73},
  number = {47},
  pages = {1076--1081},
  doi = {10.15585/mmwr.mm7347a2}
}
Kostenlos starten →